BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yiqi Z, Ziyun L, Qin F, Xingli W, Liyu Y. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts. Technol Cancer Res Treat 2020;19:1533033820980769. [PMID: 33308057 DOI: 10.1177/1533033820980769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Li G, Li H, Lai F, Duan P, Cheng M, Wang F. Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma. Journal of Immunology Research 2022;2022:1-19. [DOI: 10.1155/2022/1377565] [Reference Citation Analysis]
2 Shi Y, Wang J, Huang G, Zhu J, Jian H, Xia G, Wei Q, Li Y, Yu H. A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35699863 DOI: 10.1007/s12072-022-10354-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu Z, Zhang M, Wang W, Zhang P, Wang Y, Wang L. Global Characterization of Metabolic Genes Regulating Survival and Immune Infiltration in Osteosarcoma. Front Genet 2021;12:814843. [PMID: 35096022 DOI: 10.3389/fgene.2021.814843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu F, Xu J, Jin M, Jiang X, Li J, Li X, Chen Z, Nie J, Meng Z, Wang G. Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma. Front Mol Biosci 2021;8:705148. [PMID: 35071320 DOI: 10.3389/fmolb.2021.705148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wang P, Xiao WS, Li YH, Wu XP, Zhu HB, Tan YR. Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining. Dis Markers 2021;2021:1769635. [PMID: 34900024 DOI: 10.1155/2021/1769635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zheng D, Yang K, Chen X, Li Y, Chen Y. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment. Front Genet 2021;12:699385. [PMID: 34630511 DOI: 10.3389/fgene.2021.699385] [Reference Citation Analysis]
7 Fan L, Ru J, Liu T, Ma C. Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma. Front Cell Dev Biol 2021;9:718624. [PMID: 34552929 DOI: 10.3389/fcell.2021.718624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Chen B, Zeng Y, Liu B, Lu G, Xiang Z, Chen J, Yu Y, Zuo Z, Lin Y, Ma J. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study. Front Endocrinol (Lausanne) 2021;12:672024. [PMID: 34393996 DOI: 10.3389/fendo.2021.672024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]